Towards the Health Union’s goal to ensure that all EU patients have the medicines they need, when they need them
CRITICAL MEDICINES ACT AIMS TO:
▶ Facilitate investments for companies that increase EU manufacturing of critical medicines
▶ Incentivise supply chain diversification and resilience through public procurement
▶ Leverage the aggregated demand of participating Member States
▶ Support diversification by facilitating conclusion of strategic partnerships